Erratum: Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures (J Bone Miner Res. (2014) 29:8 (1718-28) DOI: 10.1002/jbmr.2175);Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures

Journal of Bone and Mineral Research

Volumn 29, Issue 8, 2014, Pages 1718-1728

  Seeliger, Claudine ^a   Karpinski, Katrin ^a   Haug, Alexander T ^a   Vester, Helen ^a   Schmitt, Andreas ^a   Bauer, Jan S ^a   Van Griensven, Martijn ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomarkers; Bone Healing; Fracture; miRNA; Osteoporosis

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 100; MICRORNA 122; MICRORNA 122A; MICRORNA 124; MICRORNA 125B; MICRORNA 148A; MICRORNA 21; MICRORNA 23A; MICRORNA 24; MICRORNA 637; MICRORNA 93; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE TISSUE; CELL FATE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; FRAGILITY FRACTURE; GENE EXPRESSION; HIP FRACTURE; HUMAN; HUMAN TISSUE; MALE; OSTEOLYSIS; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; UPREGULATION; BLOOD; BONE; CHEMISTRY; GENETICS; MICROARRAY ANALYSIS; PATHOPHYSIOLOGY; REPRODUCIBILITY; RISK FACTOR;

BIOMARKERS; BONE AND BONES; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; OSTEOPOROTIC FRACTURES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; UP-REGULATION;

EID: 84901226648     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2386     Document Type: Erratum

References (42)

1. Raisz LG., Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005; 115 (12): 3318-25.
2. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55 (4): 611-22.
3. Zaidi M., Skeletal remodeling in health and disease. Nat Med. 2007; 13 (7): 791-801.
4. Torricelli P, Fini M, Giavaresi G, Giardino R., Human osteoblast cultures from osteoporotic and healthy bone: biochemical markers and cytokine expression in basal conditions and in response to 1,25(OH)2D3. Artif Cells Blood Substit Immobil Biotechnol. 2002; 30 (3): 219-27.
5. Liu YZ, Dvornyk V, Lu Y, et al. A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem. 2005; 280 (32): 29011-6.
6. Gruber HE, Ivey JL, Thompson ER, Chesnut CH 3rd, Baylink DJ., Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis. Miner Electrolyte Metab. 1986; 12 (4): 246-54.
7. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004; 34 (1): 195-202.
8. Gluer CC., Monitoring skeletal changes by radiological techniques. J Bone Miner Res. 1999; 14 (11): 1952-62.
9. Garzon R, Calin GA, Croce CM., MicroRNAs in Cancer. Annu Rev Med. 2009; 60: 167-79.
10. Kosaka N, Iguchi H, Ochiya T., Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010; 101 (10): 2087-92.
11. Wang WT, Zhao YN, Han BW, Hong SJ, Chen YQ., Circulating microRNAs identified in a genome-wide serum microRNA expression analysis as noninvasive biomarkers for endometriosis. J Clin Endocrinol Metab. 2013; 98 (1): 281-9.
12. Bartel DP., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116 (2): 281-97.
13. He L, Hannon GJ., MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5 (7): 522-31.
14. Bimpaki EI, Iliopoulos D, Moraitis A, Stratakis CA., MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis. Clin Endocrinol (Oxf). 2010; 72 (6): 744-51.
15. Dahiya N, Morin PJ., MicroRNAs in ovarian carcinomas. Endocr Relat Cancer. 2010; 17 (1): F77-89.
16. Li C, Pei F, Zhu X, Duan DD, Zeng C., Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem. 2012; 45 (10-11): 727-32.
17. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010; 11 (2): 136-46.
18. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E., miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes. 2008; 57 (10): 2708-17.
19. Wang Y, Li L, Moore BT, et al. MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One. 2012; 7 (4): e34641.
20. Qi Y, Ma N, Yan F, et al. The expression of intronic miRNAs, miR-483 and miR-483*, and their host gene, Igf2, in murine osteoarthritis cartilage. Int J Biol Macromol. 2103; 61C: 43-9.
21. Eskildsen T, Taipaleenmaki H, Stenvang J, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA. 2011; 108 (15): 6139-44.
22. Hu R, Liu W, Li H, et al. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J Biol Chem. 2011; 286 (14): 12328-39.
23. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC., miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol. 2011; 179 (4): 1594-600.
24. Itoh T, Ando M, Tsukamasa Y, Akao Y., Expression of BMP-2 and Ets1 in BMP-2-stimulated mouse pre-osteoblast differentiation is regulated by microRNA-370. FEBS Lett. 2012; 586 (12): 1693-701.
25. Seeliger C, Culmes M, Schyschka L, et al. Decrease of global methylation improves significantly hepatic differentiation of Ad-MSCs: possible future application for urea detoxification. Cell Transplant. 2013; 22 (1): 119-31.
26. Livak KJ, Schmittgen TD., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001; 25 (4): 402-8.
27. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP., MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007; 27 (1): 91-105.
28. Velu VK, Ramesh R, Srinivasan AR., Circulating microRNAs as biomarkers in health and disease. J Clin Diagn Res. 2012; 6 (10): 1791-5.
29. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V., Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 2004; 5 (3): R13.
30. Adachi T, Nakanishi M, Otsuka Y, et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem. 2010; 56 (7): 1183-5.
31. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 2002; 99 (24): 15524-9.
32. Kong L, Zhu J, Han W, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011; 48 (1): 61-9.
33. Yang N, Wang G, Hu C, et al. Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res. 2013; 28 (3): 559-73.
34. He X, Zhang W, Liao L, Fu X, Yu Q, Jin Y., Identification and characterization of microRNAs by high through-put sequencing in mesenchymal stem cells and bone tissue from mice of age-related osteoporosis. PLoS One. 2013; 8 (8): e71895.
35. Sugatani T, Hruska KA., Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis. J Cell Biochem. 2013; 114 (6): 1217-22.
36. Hassan MQ, Gordon JA, Beloti MM, et al. A network connecting Runx2, SATB2, and the miR-23a27a24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA. 2010; 107 (46): 19879-84.
37. Yang L, Cheng P, Chen C, et al. miR-93/Sp7 function loop mediates osteoblast mineralization. J Bone Miner Res. 2012; 27 (7): 1598-606.
38. Zeng Y, Qu X, Li H, et al. MicroRNA-100 regulates osteogenic differentiation of human adipose-derived mesenchymal stem cells by targeting BMPR2. FEBS Lett. 2012; 586 (16): 2375-81.
39. Laine SK, Alm JJ, Virtanen SP, Aro HT, Laitala-Leinonen TK., MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J Cell Biochem. 2012; 113 (8): 2687-95.
40. Robey PG, Fedarko NS, Hefferan TE, et al. Structure and molecular regulation of bone matrix proteins. J Bone Miner Res. 1993; 8 (Suppl 2): S483-7.
41. Mizuno Y, Yagi K, Tokuzawa Y, et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun. 2008; 368 (2): 267-72.
42. Cheng P, Chen C, He HB, et al. miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B. J Bone Miner Res. 2013; 28 (5): 1180-90.